Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Brizzi
Antonella Brizzi, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20090043129 | POTENT AND SELECTIVE LIGANDS OF CANNABINOID RECEPTORS - The present invention relates to high affinity compounds, able to bind CB | 02-12-2009 |
Maria Brizzi, Torino IT
| Patent application number | Description | Published |
|---|---|---|
| 20100016226 | UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE - The present invention relates to a method for treating a cardiovascular disease, for increasing the number of circulating angiogenic cells (CAC) and/or improving the function of CAC and a method for improving vascular remodeling and/or neovascularisation. The method comprises administering to the subject a therapeutically effective amount of unacylated ghrelin or a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1 or a fragment or analog thereof having the biological activity of SEQ ID NO: 1; and to pharmaceutical compositions comprising unacylated ghrelin or a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1 or a fragment or analog thereof having the biological activity of SEQ ID NO: 1. | 01-21-2010 |
Maria Felice Brizzi, Turin IT
| Patent application number | Description | Published |
|---|---|---|
| 20110160121 | UNACYLATED GHRELIN AND ANALOGS AS THERAPEUTIC AGENTS FOR VASCULAR REMODELING IN DIABETIC PATIENTS AND TREATMENT OF CARDIOVASCULAR DISEASE - The present invention relates to a method for treating a cardiovascular disease, for increasing the number of circulating angiogenic cells (CAC) and/or improving the function of CAC and a method for improving vascular remodeling and/or neovascularisation. The method comprises administering to the subject a therapeutically effective amount of unacylated ghrelin or a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1 or a fragment or analog thereof having the biological activity of SEQ ID NO: 1; and to pharmaceutical compositions comprising unacylated ghrelin or a polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 1 or a fragment or analog thereof having the biological activity of SEQ ID NO: 1. | 06-30-2011 |
Vittorio Brizzi, Siena IT
| Patent application number | Description | Published |
|---|---|---|
| 20090043129 | POTENT AND SELECTIVE LIGANDS OF CANNABINOID RECEPTORS - The present invention relates to high affinity compounds, able to bind CB | 02-12-2009 |